
Qvar Redihaler
My Prescription
Payment
Select pharmacy




$298.94
$15.00 due at pharmacy
$298.94 - $15.00 = $283.94
$283.94 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
$298.94
Print or send this coupon to your phone
About Qvar Redihaler
Drug Details
Beclomethasone, marketed as QVAR RediHaler, is an inhaled corticosteroid designed for the maintenance treatment of asthma in individuals aged 4 and older. It effectively reduces inflammation and swelling in the lungs, thereby easing breathing and preventing symptoms like wheezing and shortness of breath. It is crucial to use this medication regularly, as it does not provide immediate relief during an asthma attack. For such situations, a quick-relief inhaler should be used as directed by your healthcare provider. This medication is typically inhaled twice daily and may cause side effects such as upper respiratory tract infections and oral thrush. Always consult with a healthcare professional before starting or changing any medication regimen.
Price history for Qvar Redihaler
1 Inhaler, 10.6GM of 80MCG/ACT
Average retail price for Qvar Redihaler
Average SaveHealth price for Qvar Redihaler
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Qvar Redihaler dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 10.6GM of 80MCG/ACT | 1 Inhaler | $298.94 | $298.94 |
| 10.6GM of 40MCG/ACT | 1 Inhaler | $221.91 | $221.91 |
| 10.6GM of 40MCG/ACT | 2 Inhalers | $438.82 | $219.41 |
| 10.6GM of 40MCG/ACT | 3 Inhalers | $655.73 | $218.58 |
| 10.6GM of 80MCG/ACT | 2 Inhalers | $592.88 | $296.44 |
| 10.6GM of 80MCG/ACT | 3 Inhalers | $886.82 | $295.61 |
Qvar Redihaler FAQs
Qvar RediHaler is used for the maintenance treatment of asthma. It helps to prevent and control symptoms such as wheezing and shortness of breath by reducing inflammation in the airways. It is not intended for the relief of acute asthma attacks.
Qvar is being discontinued due to a strategic decision by the manufacturer, which may involve factors such as market demand, production costs, or the introduction of newer alternatives. Patients using Qvar should consult their healthcare provider to discuss alternative treatment options.
Qvar is an inhaled corticosteroid. It is used to help control and prevent asthma symptoms by reducing inflammation in the airways.
An equivalent to Qvar RediHaler, which contains the active ingredient beclomethasone dipropionate, would be other inhaled corticosteroids used for asthma management. Some alternatives include Flovent (fluticasone propionate), Pulmicort (budesonide), and Asmanex (mometasone furoate). However, it is important for patients to consult with their healthcare provider to determine the most appropriate medication for their specific condition.
QVAR was not taken off the market. However, the manufacturer transitioned from QVAR to QVAR RediHaler, which is a breath-actuated inhaler. This change was made to improve ease of use and ensure proper medication delivery without the need for hand-breath coordination. If there are concerns about availability or specific formulations, it is advisable to consult a healthcare provider or pharmacist for the most current information.